<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03744533</url>
  </required_header>
  <id_info>
    <org_study_id>k （2018）38</org_study_id>
    <nct_id>NCT03744533</nct_id>
  </id_info>
  <brief_title>Head-down Position for Acute Ischemic Stroke With Large Artery Atherosclerosis</brief_title>
  <acronym>HOPES2</acronym>
  <official_title>Head-down Position for Acute Ischemic Stroke With Large Artery Atherosclerosis: a Prospective, Random, Multi-Center, Pilot Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>General Hospital of Shenyang Military Region</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>General Hospital of Shenyang Military Region</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Currently, the guideline recommended re-perfusion such as intravenous thrombolysis and&#xD;
      mechanical thrombectomy as the most effective treatment for acute ischemic stroke. However,&#xD;
      the two methods are restricted by a strict time window, which greatly limits the number of&#xD;
      the patients receiving treatment. The abundant studies have suggested that good collateral&#xD;
      circulation can provide compensatory blood supply to save the ischemic penumbra and reduces&#xD;
      the infarct volume, which improves the prognosis. How to improve collateral circulation in an&#xD;
      efficient and safe way is a clinical challenge. Our recent experiment results of the animal&#xD;
      and preliminary clinical experiments show that head-down position may significantly increase&#xD;
      cerebral perfusion and improve neurological function. Clinically, head-down position is&#xD;
      simple and easy to operate, and theoretically may increases brain perfusion and improve&#xD;
      collateral circulation. A pilot randomized clinical trial is designed to investigate the&#xD;
      effect of head-down position combined with routine rehabilitation in patients with ischemic&#xD;
      stroke.The study is designed to explore the efficacy and safety of head-down position in&#xD;
      patients with acute ischemic stroke&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 26, 2018</start_date>
  <completion_date type="Actual">August 28, 2021</completion_date>
  <primary_completion_date type="Actual">August 28, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>proportion of modified Rankin Score of 0 to 2</measure>
    <time_frame>90 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Proportion of modified Rankin Score of 0 to 1</measure>
    <time_frame>90 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>proportion of early neurological deterioration</measure>
    <time_frame>48 hours</time_frame>
    <description>Early neurological deterioration, defined as more than 4 increase in National Institute of Health stroke scale score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The occurence of stroke or other vascular events</measure>
    <time_frame>90 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>proportion of death of any cause</measure>
    <time_frame>90 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">96</enrollment>
  <condition>Ischemic Stroke</condition>
  <arm_group>
    <arm_group_label>head-down position treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>guideline-based treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>head-down position treatment</intervention_name>
    <description>the head position of subjects is lowered to 20 degrees in a supine position between 8:00-22:00 within 24h post-randomization as long as possible. During the procedure, when subjects feel intolerable, the head position will be elevated to lying flat (0 degree) for 5-10min, and then the above procedure is repeated. After 24h post-randomization, the head down procedures with -20 degrees in a supine position with duration of 1-1.5 hour will be performed three times daily at 9:00-11:00, 15:00-17:00 and 20:00-22:00, respectively.</description>
    <arm_group_label>head-down position treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>guideline-based treatment</intervention_name>
    <description>guideline-based treatment</description>
    <arm_group_label>guideline-based treatment</arm_group_label>
    <arm_group_label>head-down position treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patient age over 18 years&#xD;
&#xD;
          2. acute ischemic stroke within 24 h of onset&#xD;
&#xD;
          3. neurological deficit: 6≤NIHSS≤16&#xD;
&#xD;
          4. Large artery atherosclerosis etiology based on TOAST typing&#xD;
&#xD;
          5. the supplied vessel is the middle cerebral artery or internal carotid artery, and the&#xD;
             degree of stenosis was more than 50%.&#xD;
&#xD;
          6. first stroke onset or past stroke without obvious neurological deficit (mRS≤1)&#xD;
&#xD;
          7. Signed informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Disturbance of consciousness&#xD;
&#xD;
          2. Hemorrhagic stroke or mixed stroke&#xD;
&#xD;
          3. Combining with severe organ dysfunction&#xD;
&#xD;
          4. Past hemorrhagic stroke&#xD;
&#xD;
          5. A history of stroke with severe sequelae&#xD;
&#xD;
          6. Planned revascularization within 3 months&#xD;
&#xD;
          7. Ischemic stroke due to surgical intervention&#xD;
&#xD;
          8. participating in other clinical trials within 3 months&#xD;
&#xD;
          9. Pregnant or lactating women&#xD;
&#xD;
         10. any inappropriate patient assessed by the researcher&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Huisheng Chen, Doctor</last_name>
    <role>Study Chair</role>
    <affiliation>Neurology Department</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>General Hospital of ShenYang Military Region</name>
      <address>
        <city>Shenyang</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>November 14, 2018</study_first_submitted>
  <study_first_submitted_qc>November 15, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 16, 2018</study_first_posted>
  <last_update_submitted>September 26, 2021</last_update_submitted>
  <last_update_submitted_qc>September 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>General Hospital of Shenyang Military Region</investigator_affiliation>
    <investigator_full_name>Hui-Sheng Chen</investigator_full_name>
    <investigator_title>Department Chairman</investigator_title>
  </responsible_party>
  <keyword>head-down position</keyword>
  <keyword>Large Artery Atherosclerosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Ischemic Stroke</mesh_term>
    <mesh_term>Cerebral Infarction</mesh_term>
    <mesh_term>Atherosclerosis</mesh_term>
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

